483 Aurobindo Pharma Limited - Unit IV Apr 2017

483 Aurobindo Pharma Limited - Unit IV Apr 2017

Saleem Akhtar FDA, Scott Ballard FDA$119.00 - Available Now

FDA investigators audited the Aurobindo Pharma Limited - Unit IV - Medak District, Hyderabad, India facility and issued 7 inspectional observations (via FDA 483) on 28 Apr 2017.

Product details

  • Category: Human Drugs
  • Number of Observations: 7
  • Inspection end: 28 Apr 2017
  • Location: Medak District, Hyderabad, India
  • FEI: 3008461619
Add To Cart